Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes-Reference-Cited by-同舟云学术

Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 and -2 in Type 2 Diabetes

Published:2004-08-01 Issue:8 Volume:27 Page:2049-2051
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Tayebjee Muzahir H.¹,Lim H. Sern¹,MacFadyen Robert J.¹,Lip Gregory Y.H.¹

Affiliation:

1. From the Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, U.K

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/27/8/2049/651664/zdc00804002049.pdf

Reference17 articles.

1. Gaede P, Vendel P, Larsen N, Jensen G, Parving H, Penderson O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383–393, 2003

2. Maxwell P, Timms P, Chandran S, Gordon D: Peripheral blood alterations of TIMP-1, MMP-2, and MMP-9 in patients with type 1 diabetes. Diabet Med 18:777–780, 2001

3. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999

4. Tayebjee M, MacFadyen R, Lip GY: Extracellular matrix biology: a new frontier in linking the pathology and therapy of hypertension? J Hypertens 21:2211–2218, 2003

5. Lim H, Tayebjee M, MacFadyen R, Lip GY: Tissue inhibitor of matrix metalloproteinase-1 is a marker of left ventricular diastolic dysfunction in diabetic heart disease (Abstract). J Am Coll Cardiol 43:221A, 2004

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of diabetes mellitus severity, treatment regimen and glycaemic control on atrial fibrillation prevalence in the Polish population aged ≥ 65;Scientific Reports;2023-10-12

2. Evaluation of the effect of preoperative HbA1c value on development of postoperative atrial fibrillation in diabetic patients with on‐pump coronary artery bypass graft;Journal of Cardiac Surgery;2022-10-13

3. ADAM17 cleaves the insulin receptor ectodomain on endothelial cells and causes vascular insulin resistance;American Journal of Physiology-Heart and Circulatory Physiology;2022-10-01

4. The effect of short‐term intensive insulin therapy on inflammatory cytokines in patients with newly diagnosed type 2 diabetes;Journal of Diabetes;2022-01-18

5. A Potential Participant in Type 2 Diabetes Bone Fragility: TIMP-1 at Sites of Osteocyte Lacunar-Canalicular System;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;2021-12